SCHEMBL2835970

SCHEMBL2835970

CNCc1cc(-c2ccccc2F)c([S+]([O-])c2cccc(OC)c2)s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.39
KMT2A Q03164 4/20 0.39
MAPK1 P28482 3/20 0.39
HPGD P15428 3/20 0.39
HSD17B10 Q99714 3/20 0.39
TSHR P16473 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CASR P41180 1/20 0.37
MAPT P10636 6/20 0.36
GAA P10253 4/20 0.36
KDM4E B2RXH2 4/20 0.36
MEN1 O00255 3/20 0.36
SMN1; SMN2 Q16637 4/20 0.35
HTT P42858 1/20 0.35
TP53 P04637 3/20 0.35
RAB9A P51151 8/20 0.34
NPC1 O15118 6/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL2841111 0.92 MAPT (0.37) ALDH1A1KMT2AMAPK1HPGDHSD17B10
SCHEMBL2837973 0.81 HSD17B2 (0.39) ALDH1A1KMT2AMAPK1HPGDHSD17B10
SCHEMBL2838714 0.74 DHFR (0.39) ALDH1A1KMT2AMAPK1HPGDHSD17B10
Hydrochloric Acid SCHEMBL2844414 0.68 CYP2A6 (0.44) ALDH1A1KMT2AMAPK1MAPTKDM4E
Fumaric Acid SCHEMBL4132158 0.68 KAT6A (0.45) KMT2AMAPK1MAPTGAAMEN1
SCHEMBL3167321 0.66 ACHE (0.50) ALDH1A1KMT2AMAPK1MAPTMEN1
SCHEMBL8645345 0.63 SQOR (0.41) ALDH1A1KMT2AHPGDMAPTGAA
SCHEMBL27844337 0.62 XDH (0.46) ALDH1A1KDM4ESMN1; SMN2HTTTP53
SCHEMBL25470444 0.62 SLC6A4 (0.49) KMT2AMAPK1GAAMEN1RAB9A
SCHEMBL31038381 0.62 ACHE (0.50) ALDH1A1KMT2AHPGDHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3162798-B1 5-MEMBERED HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2021-04-14 EP claimed
EP-3162798-A1 5-MEMBERED HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2017-05-03 EP claimed
US-20100210696-A1 5-MEMBERED HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-19 US claimed
EP-2196459-A1 5-MEMBERED HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2010-06-16 EP claimed
EP-3162798-B1 5-MEMBERED HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2021-04-14 EP disclosed
EP-3162798-A1 5-MEMBERED HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2017-05-03 EP disclosed
US-8334301-B2 5-Membered heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-12-18 US disclosed
US-20100210696-A1 5-MEMBERED HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-19 US disclosed
EP-2196459-A1 5-MEMBERED HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2010-06-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210696-A1 5-MEMBERED HETEROCYCLIC COMPOUND NPY4R, NPY5R, NPY1R ALDH1A1 2505/4885KMT2A 4103/4885MAPK1 2435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.